Navigation Links
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
Date:10/26/2008

nal samples from the MERIT trial using the enhanced Trofile assay. These samples had been previously archived by Monogram and laboratory personnel had no knowledge of previous testing results or clinical outcomes data from the trial. The results obtained with the enhanced sensitivity version of the Trofile Assay were provided to Pfizer who conducted the clinical analysis in accordance with a prespecified statistical analysis plan.

Using the enhanced Trofile assay, 15% of MERIT screening samples previously defined as R5 HIV were reclassified as CXCR4-using (Dual/Mixed) HIV, and thus would have been unable to participate in the study. Analyses restricted to individuals with CCR5-tropic HIV as determined by the enhanced Trofile assay demonstrated an overall improvement in Selzentry efficacy relative to efavirenz (the control arm of the trial). In the new retrospective analysis of the MERIT trial samples, powered by the enhanced Trofile assay, 68% of individuals achieved HIV-1 RNA <50 copies/mL at week 48 in both the Selzentry and efavirenz arms of the study.

"The data presented this week demonstrate the value of selecting the appropriate individuals for Selzentry therapy," said William Young, Monogram CEO. "With proper patient selection, using Trofile, a positive response to therapy can be expected, even in early stage individuals where the standard of care is already very high. Monogram's commitment to scientific excellence is clearly reflected in the data presented this week, which provides increased hope for individuals infected with HIV that new classes of drug and new drugs, such as Selzentry, may benefit all HIV infected individuals, not just those individuals with advanced disease."

"Selzentry already has a proven record as a safe and effective therapeutic option for treatment-experienced HIV positive patients," said W. David Hardy, MD, Director, Division of Infectious Diseases at Cedars-Sinai Medical Center and Associate Professor of Medici
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
4. RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial
5. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
6. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
7. New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
8. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
9. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
10. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
11. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015  OrthoSpace Ltd. ("OrthoSpace" ... first three patients in its US Investigational Device ... 184 patient randomized, single blinded control study that ... conventional repair or partial repair for the treatment ... InSpace is currently commercially available outside of ...
(Date:7/6/2015)... PARIS , July 6, 2015 ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... Japan,s Ministry of Health, ... Confocal Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe. ... Cellvizio AQ -Flex™ 19 miniprobe is comprised of ...
(Date:7/6/2015)... , June 29, 2015 ... of the "Pharmaceutical Packaging Market in North America ... pharmaceutical packaging market in North America ... the period 2014-2019. International regulations regarding ... drug manufacturers, which in turn fuels adoption of sustainable ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3
... SOUTH SAN FRANCISCO, Calif., Dec. 7, 2011 Rigel ... that Raul Rodriguez, the company,s president and chief operating ... the Oppenheimer 22nd Annual Healthcare Conference in New York ... (Logo: http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) ...
... (NYSE AMEX: IBIO ) today announced that Jules ... a Managing Director of the Company for at least the ... development activity.  Mr. Musing, formerly a Senior Executive at Johnson ... 2011.  In the course of his career in the Pharmaceutical ...
Cached Medicine Technology:Jules Musing to Lead Business Development Effort 2Jules Musing to Lead Business Development Effort 3
(Date:7/6/2015)... ... ... TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, which takes ... and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the app ... rooms will look like before they even start renovating.. , Whether a person is ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... Medical Spa industries, announces the return of its complimentary educational webinar series ... aesthetic medical business leaders creates success for their clients through targeted marketing, sales, ...
(Date:7/6/2015)... ... 2015 , ... Understanding the new ICD-10 requirements is crucial ... transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the nation, ... ten tips are timely and relevant guidelines to help radiology practices avoid coding ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and ... of the medical field to access and use this “Big Data” to improve health ... and Chief Executive Officer of the Mount Sinai Health System in New York City. ...
(Date:7/6/2015)... Atlanta, Georgia (PRWEB) , ... July 06, 2015 ... ... University has received nearly $400,000 in grant funds to support a three-year effort ... Atlanta. , The work will be conducted in partnership with the Morehouse School ...
Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... (HealthDay News) -- For newly diagnosed cancer patients, appointments with ... those with private health insurance, according to U.S. researchers. ... assistants posing as new cancer patients were unable to obtain ... The findings, from a team at the Perelman School of ...
... data presented at The American Society of Clinical Oncology ... tumor vaccine HSPPC-96 for treating recurrent gliobastoma (GBM) has ... to three times more than the current median survival ... Hospitals Case Medical Center, University of California, San Francisco ...
... epidemic, a once-rare form of cancer known as Kaposi,s sarcoma ... was best illustrated by Tom Hanks, who portrayed a gay ... co-workers in the 1993 movie "Philadelphia." A few years ... searching for a postdoctoral position. He found one, in Philadelphia, ...
... , THURSDAY, June 2 (HealthDay News) -- They are ... new research reveals that used faceshields are more likely to ... equipment managers, conducted by Ohio State University, also found that ... replacement policy in place for used or damaged shields. ...
... , THURSDAY, June 2 (HealthDay News) -- Noisy operating rooms ... infections, new study findings suggest. In the report, ... of Surgery , the Swiss researchers also said these surgical ... hospital stays. "SSIs lead to patients spending up to ...
... than 70 with glioblastoma, the most common and aggressive ... for those living in poorer areas and older than ... presented at the American Society of Clinical Oncology annual ... on Saturday, June 4. ( ABSTRACT #6089 ). ...
Cached Medicine News:Health News:U.S. Cancer Patients Face Barriers to Care, Study Finds 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 4Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 5Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 6Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 7Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 8Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 9Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 10Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 11Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 12Health News:FSU scientist leads research on AIDS-related cancer 2Health News:FSU scientist leads research on AIDS-related cancer 3Health News:Used Football Faceshields May Break on Impact 2Health News:Noisy ORs Linked to Raised Risk of Surgical Site Infection 2Health News:ASCO: Glioblastoma in the 21st century: Wealthier patients living longer than poorer patients 2
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... concave seats and large backrests with lumbar ... armrests, and casters and glides. • Choose ... a variety of environments including: industry, education, ... and office. • With cast aluminum base ...
... concave seats and large backrests with lumbar ... armrests, and casters and glides. • Choose ... a variety of environments including: industry, education, ... and office. • With cast aluminum base ...
Medicine Products: